|
|
慢性高原病相关细胞因子研究进展
|
Abstract:
慢性高原病是由高原低压缺氧引起的一种高原特发性疾病。由于高原病的发病机制十分复杂，仍有许多问题迄今尚不清楚。近年来的许多研究显示，慢性高原病患者血浆中部分细胞因子水平发生变化，本文通过对参与高原病相关细胞因子最新的研究进展进行综述，为进一步探讨高原病的发病机制和寻找新的治疗靶点提供新思路。
Chronic high altitude disease is a kind of high altitude idiopathic disease caused by low altitude hy-poxia. Because the pathogenesis of plateau disease is very complex, there are still many problems that are still unclear. In recent years, many studies have shown that the level of some cytokines in the plasma of patients with chronic plateau disease has changed. This article reviews the latest re-search progress of cytokines involved in plateau disease, providing new ideas for further exploring the pathogenesis of plateau disease and finding new therapeutic targets.
| [1] | 国际高原医学会慢性高原病专家小组. 第六届国际高原医学和低氧生理学术大会颁布慢性高原病青海诊断标准[J]. 青海医学院学报, 2005(1): 3-5. |
| [2] | 单增卓嘎, 李康, 格桑罗布. 高原红细胞增多症的相关研究进展[J]. 西藏医药, 2015, 36(4): 82-85. |
| [3] | 马轶, 罗伟. 慢性高原病的最新治疗研究进展[J]. 中西医结合心血管病电子杂志, 2020, 8(35): 26-46. |
| [4] | 董兆梅, 郝玉姣, 张元元. 高原性红细胞增多症的治疗研究进展[J]. 现代医药卫生, 2021, 37(8): 1309-1312. |
| [5] | 吴天一. 我国青藏高原慢性高原病研究的最新进展[J]. 中国实用内科杂志, 2012, 32(5): 321-323. |
| [6] | 于前进, 孔佩艳. 高原红细胞增多症发病机制的研究进展[J]. 国际输血及血液学杂志, 2014, 37(1): 74-77. |
| [7] | Benderro, G.F., Sun, X., Kuang, Y., et al. (2012) Decreased VEGF Expression and Microvascular Density, but Increased HIF-1 and 2alpha Accumulation and EPO Expression in Chronic Moderate Hyperoxia in the Mouse Brain. Brain Research, 1471, 46-55. https://doi.org/10.1016/j.brainres.2012.06.055 |
| [8] | Liu, C., Shi, Y., Han, Z., et al. (2003) Suppression of the Dual-Specificity Phosphatase MKP-1 Enhances HIF-1 Trans- Activation and Increases Expression of EPO. Biochemical and Biophysical Research Communications, 312, 780-786.
https://doi.org/10.1016/j.bbrc.2003.10.186 |
| [9] | Yu, Y., Ma, L., Zhang, H., et al. (2020) EPO Could Be Regulated by HIF-1 and Promote Osteogenesis and Accelerate Bone Repair. Artificial Cells, Nanomedicine, and Biotechnology, 48, 206-217.
https://doi.org/10.1080/21691401.2019.1699827 |
| [10] | 李素芝, 牟信兵, 薛增军, 郑碧海. 高原红细胞增多症患者血清EPO含量变化及其意义[J]. 高原医学杂志, 1998(3): 32-33. |
| [11] | Ronzoni, L., Bonara, P., Rusconi, D., et al. (2008) Erythroid Differentiation and Maturation from Peripheral CD34+ Cells in Liquid Culture: Cellular and Molecular Characterization. Blood Cells, Molecules, and Diseases, 40, 148-155.
https://doi.org/10.1016/j.bcmd.2007.07.006 |
| [12] | 周其全, 刘福玉, 郑必海, 等. 白细胞与白细胞介素增高在急性高原病并发多器官功能障碍中的作用及临床意义[J]. 中国危重病急救医学, 2007, 19(10): 588-592. |
| [13] | 唐琼琳, 高宏生, 刘丽华, 等. 急性高原缺氧大鼠脑皮质相关细胞因子变化及蕨麻的保护作用[J]. 中国中西医结合急救杂志, 2012, 19(3): 137-140. |
| [14] | Schmid, T., Zhou, J. and Brune, B. (2004) HIF-1 and p53: Communication of Transcription Factors under Hypoxia. Journal of Cellular and Molecular Medicine, 8, 423-431. https://doi.org/10.1111/j.1582-4934.2004.tb00467.x |
| [15] | 周文婷. HIF-1活性调控机制的研究进展[J]. 生理科学进展, 2020, 51(6): 443-448. |
| [16] | Mcclain, D.A., et al. (2013) Decreased Serum Glucose and Glycosylated Hemoglo-bin Levels in Patients with Chuvash Polycythemia: A Role for HIF in Glucose Metabolism. Journal of Molecular Medi-cine, 91, 59-67.
https://doi.org/10.1007/s00109-012-0961-5 |
| [17] | Johnson, R.S. and Weidemann, A. (2008) Biology of HIF-1alpha. Cell Death & Differentiation, 15, 621-627.
https://doi.org/10.1038/cdd.2008.12 |
| [18] | 李晓娜, 任海林, 马德庆, 等. 高原红细胞增多症患者外周血低氧诱导因子-1α水平的检测[J]. 临床检验杂志, 2012, 30(5): 388-389. |
| [19] | 冯玫, 李玉翠. EPO与EPO受体的研究进展[J]. 白血病？淋巴瘤, 2005, 14(4): 254-256. |
| [20] | Vizcardo-Galindo, G., Leon-Velarde, F., Villafuerte, F.C. (2020) High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders. High Altitude Medicine & Biology, 21, 92-98.
https://doi.org/10.1089/ham.2019.0118 |
| [21] | Xie, Y., Shi, X., Sheng, K., et al. (2018) PI3K/Akt Signaling Trans-duction Pathway, Erythropoiesis and Glycolysis in Hypoxia (Review). Molecular Medicine Reports, 19, 783-791. https://doi.org/10.3892/mmr.2018.9713 |
| [22] | Li, P., et al. (2011) Regulation of Bone Marrow Hematopoietic Stem Cell Is Involved in High-Altitude Erythrocytosis. Experimental Hematology, 39, 37-46. |
| [23] | 史子毕, 朱玲玲. IL-6与高原病的研究进展[J]. 中国高原医学与生物学杂志, 2021, 42(3): 190-194. |
| [24] | 莎珍次, 仁布芷, 张世馥. 高原红细胞增多症患者血细胞中IL-6的研究[J]. 中华血液学杂志, 2003(4): 42-43. |
| [25] | Querido, J.S., Sheel, A.W., Cheema, R., et al. (2012) Effects of 10 Days of Modest Intermittent Hypoxia on Circulating Measures of Inflammation in Healthy Humans. Sleep and Breathing, 16, 657-662.
https://doi.org/10.1007/s11325-011-0555-4 |
| [26] | Kritas, S.K., Saggini, A., Cerulli, G., et al. (2014) Interrelationship between IL-3 and Mast Cells. Journal of Biological Regulators and Homeostatic Agents, 28, 17-21. |
| [27] | Zbigniew, S., Anna, L., Czes Aw, G., et al. (2014) Hematological Parameters, and Hematopoietic Growth Factors: Epo and IL-3 in Response to Whole-Body Cryostimulation (WBC) in Military Academy Students. PLOS ONE, 9, e93096.
https://doi.org/10.1371/journal.pone.0093096 |
| [28] | 于前进, 孔佩艳, 曾东风, 等. 蛋白芯片检测高原红细胞增多症患者血清炎症细胞因子表达的探索研究[J]. 中国输血杂志, 2015, 28(3): 251-255. |
| [29] | 马筱洁, 马聪聪, 刘鸿春, 等. 高原移居与返回平原青年人群血液生化及细胞因子指标分析[J]. 国际检验医学杂志, 2022, 43(24): 3001-3005. |
| [30] | 王宇亮, 高钰琪, 刘福玉. 模拟高原缺氧不依赖肺动脉高压促进大鼠右心室ACE2的表达[J]. 中国病理生理杂志, 2009, 25(7): 1298-1302. |
| [31] | Walter, R., Maggiorini, M., Scherrer, U., et al. (2001) Effects of High-Altitude Exposure on Vascular Endothelial Growth Factor Levels in Man. European Journal of Applied Physiolo-gy, 85, 113-117.
https://doi.org/10.1007/s004210100419 |
| [32] | 王洪斌, 李素芝, 姚文新, 等. 高原红细胞增多症的VEGF变化研究[J]. 西南国防医药, 2006, 16(2): 167-168. |
| [33] | 于前进, 孔佩艳. 与高原红细胞增多症有关的血清炎症因子的研究进展[J]. 西南国防医药, 2014, 24(9): 1026-1027. |
| [34] | 孙鑫波, 刘朝东. MIP-1α与MMP-9在免疫炎症反应中作用及其关系研究进展[J]. 中国免疫学杂志, 2012, 28(5): 474-477. |
| [35] | 柴克霞, 贾乃镛, 李占全, 崔森, 杨发满. 高原红细胞增多症患者血浆MIP-1α水平[J]. 中华血液学杂志, 2004, 25(3): 179. |
